Wei-Chao Chang - JoVE Visualize

Showing results (11-20 of 91) with videos related to

Pageof 10

Sort By:

Plos One|November 17, 2015

ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell CarcinomaSheng-Ta Tsai, Po-Jen Wang, Nia-Jhen Liou, et al.

Nature Communications|December 16, 2025

TRIM37-PARP1-TET1 axis maintains stemness and prevents osteoporosis by inhibiting DNMT1 alternative splicing via 5hmC regulationChun-Te Ho, Ling-Hui Li, Wei-Chao Chang, et al.

Journal of Cellular Biochemistry|May 20, 2009

Identification of the major TG4 cross-linking sites in the androgen-dependent SVS I exclusively expressed in mouse seminal vesicleHuan-Chin Tseng, Han-Jia Lin, Jyh-Bing Tang, et al.

American Journal of Translational Research|April 23, 2015

Proteasome inhibition enhances the killing effect of BikDD gene therapyYe Sun, Mariano Ponz-Sarvise, Shih-Shin Chang, et al.

AJR. American Journal of Roentgenology|March 24, 2006

CT and MRI of adnexal masses in patients with primary nonovarian malignancyWei-Chao Chang, Maya D Meux, Benjamin M Yeh, et al.

International Journal of Molecular Sciences|August 10, 2024

Aqueous Extracts of Ocimum gratissimum Sensitize Hepatocellular Carcinoma Cells to Cisplatin through BRCA1 InhibitionJing-Huei Chen, Tsai-Hui Lin, Yu-Chuan Chien, et al.

Plos One|November 14, 2013

Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphomaKung-Chao Chang, Wei-Chao Chang, Yao Chang, et al.

American Journal of Cancer Research|December 12, 2022

Combination treatment of arsenic trioxide and osimertinib in recurrent and metastatic head and neck squamous cell carcinomaChing-Yun Hsieh, Wei-Chao Chang, Ching-Chan Lin, et al.

Oncology Reports|April 9, 2026

NF‑κB‑driven LUZP1 promotes metastasis and chemoresistance in head and neck squamous cell carcinomaChen-Yuan Lin, Ching-Yun Hsieh, Hsin-Chi Lan, et al.

Pharmaceuticals (Basel, Switzerland)|October 26, 2024

Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 InhibitionShu-Yu Hu, Tsai-Hui Lin, Chung-Yu Chen, et al.

Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:

Pageof 10

Plos One|November 17, 2015

ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell CarcinomaSheng-Ta Tsai, Po-Jen Wang, Nia-Jhen Liou, et al.

Nature Communications|December 16, 2025

TRIM37-PARP1-TET1 axis maintains stemness and prevents osteoporosis by inhibiting DNMT1 alternative splicing via 5hmC regulationChun-Te Ho, Ling-Hui Li, Wei-Chao Chang, et al.

Journal of Cellular Biochemistry|May 20, 2009

Identification of the major TG4 cross-linking sites in the androgen-dependent SVS I exclusively expressed in mouse seminal vesicleHuan-Chin Tseng, Han-Jia Lin, Jyh-Bing Tang, et al.

American Journal of Translational Research|April 23, 2015

Proteasome inhibition enhances the killing effect of BikDD gene therapyYe Sun, Mariano Ponz-Sarvise, Shih-Shin Chang, et al.

AJR. American Journal of Roentgenology|March 24, 2006

CT and MRI of adnexal masses in patients with primary nonovarian malignancyWei-Chao Chang, Maya D Meux, Benjamin M Yeh, et al.

International Journal of Molecular Sciences|August 10, 2024

Aqueous Extracts of Ocimum gratissimum Sensitize Hepatocellular Carcinoma Cells to Cisplatin through BRCA1 InhibitionJing-Huei Chen, Tsai-Hui Lin, Yu-Chuan Chien, et al.

Plos One|November 14, 2013

Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphomaKung-Chao Chang, Wei-Chao Chang, Yao Chang, et al.

American Journal of Cancer Research|December 12, 2022

Combination treatment of arsenic trioxide and osimertinib in recurrent and metastatic head and neck squamous cell carcinomaChing-Yun Hsieh, Wei-Chao Chang, Ching-Chan Lin, et al.

Oncology Reports|April 9, 2026

NF‑κB‑driven LUZP1 promotes metastasis and chemoresistance in head and neck squamous cell carcinomaChen-Yuan Lin, Ching-Yun Hsieh, Hsin-Chi Lan, et al.

Pharmaceuticals (Basel, Switzerland)|October 26, 2024

Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 InhibitionShu-Yu Hu, Tsai-Hui Lin, Chung-Yu Chen, et al.

Pageof 10